Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.49 |
| ▸ | NQO2 | P16083 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | ACP3 | P15309 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.45 |
| ▸ | DAO | P14920 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29756497 | 1.00 | CYP1A2 (0.54) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A | |
| Fluoride SCHEMBL27772173 | 0.98 | CYP1A2 (0.52) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A | |
| SCHEMBL27350086 | 0.89 | CDYL (0.52) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A | |
| SCHEMBL11797323 | 0.88 | HPRT1 (0.54) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A | |
| Acetic Acid SCHEMBL27857297 | 0.87 | TDP1 (0.56) | CYP1A2MTNR1ANQO2TDP1ACP3 | |
| SCHEMBL79742 | 0.87 | CYP1A2 (0.50) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A | |
| SCHEMBL3047898 | 0.85 | CYP1A2 (0.62) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A | |
| SCHEMBL6680287 | 0.85 | CYP1A2 (0.48) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A | |
| SCHEMBL6679058 | 0.84 | CYP1A2 (0.47) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A | |
| SCHEMBL6686054 | 0.84 | CYP1A2 (0.47) | CYP1A2CYP2C19CYP2C9CYP2D6MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 430 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112771684-B | Ink composition for manufacturing organic semiconductor device | 株式会社大赛璐 | 2024-07-12 | — | — | CN | claimed |
| CN-103319485-B | 6-(beta-alkylnaphthy)mercaptopurine compound, and synthesis method and application thereof | JILIN BIAODA TECHNOLOGY CO LTD | 2015-05-27 | — | — | CN | claimed |
| CN-104447515-A | New intermediates for preparing ceritinib and preparation method of intermediate | 2Y CHEM LTD | 2015-03-25 | — | — | CN | claimed |
| CN-103319485-A | 6-(beta-alkylnaphthy)mercaptopurine compound, and synthesis method and application thereof | JILIN BIAODA TECHNOLOGY CO LTD | 2013-09-25 | — | — | CN | claimed |
| CN-103087707-A | Fluorescent chemical sensor and preparation method and application thereof | UNIV JIANGSU TECHNOLOGY | 2013-05-08 | — | — | CN | claimed |
| CN-101481360-A | Sulfur-bearing photo-curing compound and preparation thereof | UNIV ZHONGSHAN (CN) | 2009-07-15 | — | — | CN | claimed |
| CN-1245805-A | Method for preparing substituted piperidine-epoxide | HOFFMANN LA ROCHE (CH) | 2000-03-01 | — | — | CN | claimed |
| US-4492798-A | CARBONYLATION OF ARLALKYL HALIDE WITH CARBON MONOXIDE IN THE PRESE | ETHYL CORPORATION (US) | 1985-01-08 | — | — | US | claimed |
| US-20260085093-A1 | INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260078147-A1 | INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2026-03-19 | — | — | US | disclosed |
| US-12479887-B2 | Inhibitors for protein n-terminal methyltransferase and uses thereof | PURDUE RESEARCH FOUNDATION (US) | 2025-11-25 | — | — | US | disclosed |
| EP-3630779-B1 | ANTIBIOTIC RESISTANCE BREAKERS | KING S COLLEGE LONDON (GB) | 2025-09-03 | — | — | EP | disclosed |
| CN-112771684-B | Ink composition for manufacturing organic semiconductor device | 株式会社大赛璐 | 2024-07-12 | — | — | CN | disclosed |
| CN-114716296-B | Efficient halogenation synthesis method of alkyl halide | 润药仁智(北京)科技有限公司 | 2023-12-12 | — | — | CN | disclosed |
| US-4185115-A | Antilipidemic para-[aryl(alkyl or alkenyl)amino]-benzoic acid derivatives | AMERICAN CYANAMID COMPANY (US) | 1980-01-22 | — | — | US | disclosed |
| US-4182902-A | P-(P'-CHLOROBENZYL) PHENOXYACETIC ACID | SIEGFRIED AKTIENGESELLSCHAFT (CH) | 1980-01-08 | — | — | US | disclosed |
| EP-0003560-A2 | Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations | THE WELLCOME FOUNDATION LIMITED (GB) | 1979-08-22 | — | — | EP | disclosed |
| US-4153803-A | Cholesterol-lowering phenoxyalkanoic acid esters | SIEGFRIED AKTIENGESELLSCHAFT (CH) | 1979-05-08 | — | — | US | disclosed |
| US-4133830-A | RECYCLING BY-PRODUCTS TO SUCCESSIVE RUNS TO IMPROVE YIELD | STAUFFER CHEMICAL COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
| US-4076746-A | FROM AN ALKYL OR ARYL HALIDE AND PHOSPHORUS SESQUISULFIDE | STAUFFER CHEMICAL COMPANY (US) | 1978-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085093-A1 | INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF | GNMT, PRMT5, INMT | CYP1A2 3577/4885CYP2C19 3481/4885CYP2C9 2416/4885 |
| US-12479887-B2 | Inhibitors for protein n-terminal methyltransferase and uses thereof | GNMT, PRMT1, PRMT5 | CYP1A2 4604/4885CYP2C19 4838/4885CYP2C9 4750/4885 |
| US-20260078147-A1 | INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF | SMYD2, INMT, PRMT6 | CYP1A2 3777/4885CYP2C19 3349/4885CYP2C9 3394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.